Physician profile
Douglas Dedo
NPI 1164473096
$1,455.04
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $51.03 · 2021: $282 · 2022: $251 · 2023: $74.92 · 2024: $97.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $343.37 | 2019-2022 | |
| Stryker Corporation | $313.58 | 2019-2021 | |
| Allergan, INC. | $244.38 | 2019-2022 | |
| Acclarent, INC | $184.48 | 2019 | |
| Abbvie INC. | $172.77 | 2023-2024 | Botox |
| Intersect Ent, INC. | $94.30 | 2021 | |
| Smith+Nephew, INC. | $86.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Dedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.